Novel Therapeutic Targets in Heart Failure: The Phospholipase Cβ1b–Shank3 Interface

Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s18480
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

PLCB2 (Phospholipase C, Beta 2)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2008English

Endothelial Dysfunction in Chronic Heart Failure: Assessment, Findings, Significance, and Potential Therapeutic Targets

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

MTE11.01 Novel Therapeutic Targets in SCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PLCB1 (Phospholipase C, Beta 1 (Phosphoinositide-Specific))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Beta-Blockers for Heart Failure

Cochrane Database of Systematic Reviews
2016English

Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?

Mediators of Inflammation
ImmunologyCell Biology
2016English

In Search of New Therapeutic Targets and Strategies for Heart Failure: Recent Advances in Basic Science

The Lancet
Medicine
2011English

Novel Therapeutic Targets in Inflammatory Bowel Disease

Prescriber
Pharmacology
2019English

Beta-Blockers for Heart Failure

2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy